A carregar...
Targeting mTOR for the treatment of B cell malignancies
Mechanistic target of rapamycin (mTOR) is a serine/threonine kinase that functions as a key regulator of cell growth, division and survival. Many haematologic malignancies exhibit elevated or aberrant mTOR activation, supporting the launch of numerous clinical trials aimed at evaluating the potentia...
Na minha lista:
| Publicado no: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5061788/ https://ncbi.nlm.nih.gov/pubmed/26805380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12888 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|